186 related articles for article (PubMed ID: 347289)
1. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for the treatment of immune deficiency states.
Lenarsky C; Parkman R
Bone Marrow Transplant; 1990 Dec; 6(6):361-9. PubMed ID: 1965792
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of the Wiskott-Aldrich syndrome by a graft of allogeneic bone marrow].
Fischer A; Durandy A; Bordigoni P; Virelizier JL; Vilmer E; Arnaud-Battandier F; Lagrue A; Olive D; Griscelli C
Arch Fr Pediatr; 1984 Nov; 41(9):611-6. PubMed ID: 6391414
[TBL] [Abstract][Full Text] [Related]
5. Unrelated donor BMT for Wiskott-Aldrich syndrome.
Lenarsky C; Weinberg K; Kohn DB; Parkman R
Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
[TBL] [Abstract][Full Text] [Related]
6. Marrow transplantation for nonmalignant disorders.
Thomas ED
N Engl J Med; 1978 Apr; 298(17):963-4. PubMed ID: 417247
[No Abstract] [Full Text] [Related]
7. Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with Wiskott-Aldrich syndrome.
Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schumm M; Handgretinger R
Bone Marrow Transplant; 2000 Jul; 26(2):235-7. PubMed ID: 10918439
[TBL] [Abstract][Full Text] [Related]
8. Unrelated bone marrow transplantation in a Wiskott-Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor.
La Nasa G; Pizzati A; Ledda A; Vacca A; Arras M; Contu L
Haematologica; 1996; 81(2):178-81. PubMed ID: 8641653
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation for an infant with neutrophil dysfunction.
Camitta BM; Quesenberry PJ; Parkman R; Boxer LA; Stossel TP; Cassady JR; Rappeport JM; Nathan DG
Exp Hematol; 1977 Mar; 5(2):109-16. PubMed ID: 321233
[TBL] [Abstract][Full Text] [Related]
10. Successful bone marrow transplantation in sensitized recipients.
Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
[TBL] [Abstract][Full Text] [Related]
11. [Allogenic bone marrow transplantation in Wiskott-Aldrich syndrome].
Maldonado MS; Muñoz A; Otheo de Tejada E; Roldán E; Aymerich L; Brieva JA
Med Clin (Barc); 1993 Sep; 101(7):258-60. PubMed ID: 7746001
[TBL] [Abstract][Full Text] [Related]
12. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
[TBL] [Abstract][Full Text] [Related]
13. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
15. Experience with second marrow transplants.
Wright SE; Thomas ED; Buckner CD; Clift RA; Fefer A; Neiman PE; Storb R
Exp Hematol; 1976 Jul; 4(4):221-6. PubMed ID: 782896
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
17. [Platelet function after allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome].
Megido M; Cesar JM; Maldonado MS; Otheo E; Muñoz A; Navarro JL
Sangre (Barc); 1993 Jun; 38(3):233-4. PubMed ID: 8211550
[TBL] [Abstract][Full Text] [Related]
18. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
[TBL] [Abstract][Full Text] [Related]
19. Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation.
Rappeport JM; Parkman R; Newburger P; Camitta BM; Chusid MJ
Am J Med; 1980 Apr; 68(4):605-9. PubMed ID: 6989239
[TBL] [Abstract][Full Text] [Related]
20. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
